Literature DB >> 26015699

Leukoplakia: A short review on malignant potential.

K M K Masthan1, N Aravindha Babu1, S Leena Sankari1, C Priyadharsini1.   

Abstract

Oral leukoplakia is one of the most common potentially malignant disorders. Right diagnosis of potentially malignant disorders may help to prevent these lesions from malignant transformation. Proper understanding, recognizing, identification and differentiating these lesions from normal mucosa are necessary for proper treatment.

Entities:  

Keywords:  Leukoplakia; malignant potential; types

Year:  2015        PMID: 26015699      PMCID: PMC4439659          DOI: 10.4103/0975-7406.155890

Source DB:  PubMed          Journal:  J Pharm Bioallied Sci        ISSN: 0975-7406


The word leukoplakia means white patch (leuko-white, plakia-patch). It is considered as the premalignant lesions, but now included in a broader term for common usage of tobacco in the form of smoking and chewing. High-risk of malignant transformation is encountered if the risk factors are not eliminated. It has been reported that many oral squamous cell carcinoma develops from the potentially malignant disorders. Correct diagnosis and the right treatment at right time of potentially malignant disorders may prevent malignant transformation of these lesions. The term “potentially malignant disorders” was defined by World Health Organization (WHO) as the risk of malignancy being present in a lesion or condition either during the time of initial diagnosis or at a future date.[1] WHO defined leukoplakia as “a white plaque of questionable risk having excluded (other) known diseases or disorders that carry no increased risk for cancer.”[23]

Classification

Clinically it is classified into four types: Early or thin Homogenous or thick Granular or verruciform and Speckled or erythroleukoplakia. Each subdivision has a different malignant transformation potential.[3]

Malignant Potential

Leukoplakia is considered has the most common premalignant lesion. According to the systematic review, the estimated prevalence rate of leukoplakia is 2% worldwide.[4] Those lesions present particularly in the floor of the mouth, tongue, lip and vermilion have a high risk of malignant potential.

Types of Leukoplakia and Their Malignant Potentia

Thin leukoplakia frequently becomes malignant without any clinical changes.[5]

Other Forms of Leukoplakia

Proliferative verrucous leukoplakia

It is the most aggressive form of leukoplakia and was first described by Hansen et al. in 1985. It is multifocal parch often presents with surface projections. The lesion usually tends to spread slowly. Most commonly seen in gingival but other site are also affected.[4] Bagan et al.[6] and Batsakis et al.[7] have reported that squamous cell carcinoma development in 63.3% and 100% of proliferative verrucous leukoplakia respectively. Usually, the transformation occurs within 8 years of initially diagnosis of proliferative verrucous leukoplakia.[4]

Candidal leukoplakia

Candidal leukoplakia (CL) is a chronic form of candidiasis. It is generally characterized by firm, white, leathery plaques. The lesion is commonly seen on the cheeks, lips, palate, and tongue. Epithelial dysplasia commonly occurs 4–5 times more frequently in CL when compared with other forms of leukoplakia.[8]

Five Clinical Criteria Demonstrate a Particularly High Risk of Malignant Change

The high risk is considered to be the verrucous type If the lesion is associated with erosion or ulceration then, the lesion is suggested to have high malignant potential The presence of a nodule in the lesion indicates higher malignant potential A lesion that is hard and indurative in its periphery is predictive of malignant change Oral leukoplakia seen in the anterior floor of the mouth and undersurface of the tongue is strongly linked to malignant potential.[9]

Conclusion

Most cancers can be prevented if diagnosed at early stages. It is well known fact that most cancers arise from the potentially malignant disorders. Potentially malignant disorders are often overlooked due to inadequate knowledge. Proper understanding, recognizing, identification and differentiating these lesions and thorough knowledge about the malignant potential of these lesions will ensure proper treatment and pay a key role in saving patient life.
  5 in total

Review 1.  Proliferative verrucous leukoplakia and its related lesions.

Authors:  J G Batsakis; P Suarez; A K el-Naggar
Journal:  Oral Oncol       Date:  1999-07       Impact factor: 5.337

Review 2.  Oral premalignant lesions: from a clinical perspective.

Authors:  Teruo Amagasa; Masashi Yamashiro; Narikazu Uzawa
Journal:  Int J Clin Oncol       Date:  2011-01-12       Impact factor: 3.402

3.  Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma.

Authors:  Jose V Bagan; Yolanda Jimenez; Jose M Sanchis; Rafael Poveda; Mari A Milian; Judith Murillo; Crispian Scully
Journal:  J Oral Pathol Med       Date:  2003-08       Impact factor: 4.253

Review 4.  Pooled estimate of world leukoplakia prevalence: a systematic review.

Authors:  Stefano Petti
Journal:  Oral Oncol       Date:  2003-12       Impact factor: 5.337

Review 5.  Oral potentially malignant disorders: an overview of more than 20 entities.

Authors:  Hamed Mortazavi; Maryam Baharvand; Masoumeh Mehdipour
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2014-03-05
  5 in total
  5 in total

1.  Pharmacokinetic and Metabolic Profiling of Key Active Components of Dietary Supplement Magnolia officinalis Extract for Prevention against Oral Carcinoma.

Authors:  Dinh Bui; Li Li; Taijun Yin; Xinli Wang; Song Gao; Ming You; Rashim Singh; Ming Hu
Journal:  J Agric Food Chem       Date:  2020-06-04       Impact factor: 5.279

2.  Noninvasive assessment of oral lesions using elastic light single-scattering spectroscopy: a pilot study.

Authors:  Aslinur Sircan-Kucuksayan; Neslihan Yaprak; Alper Tunga Derin; İrem Hicran Ozbudak; Murat Turhan; Murat Canpolat
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-03       Impact factor: 2.503

3.  Nigella sativa extract kills pre-malignant and malignant oral squamous cell carcinoma cells.

Authors:  Selma Dagtas; Robert J Griffin
Journal:  J Herb Med       Date:  2021-05-21       Impact factor: 2.542

4.  Association between oral leukoplakia and risk of upper gastrointestinal cancer death: A follow-up study of the Linxian General Population Trial.

Authors:  He Liang; Zhao Yang; Jian-Bing Wang; Pei Yu; Jin-Hu Fan; You-Lin Qiao; Philip R Taylor
Journal:  Thorac Cancer       Date:  2017-09-20       Impact factor: 3.500

5.  Malignant Transformation in Leukoplakia and Its Associated Factors in Southern Iran: A Hospital Based Experience.

Authors:  Alireza Barfi Qasrdashti; Mina Seied Habashi; Peyman Arasteh; Mahshid Torabi Ardakani; Zahra Abdoli; Seyed Sajjad Eghbali
Journal:  Iran J Public Health       Date:  2017-08       Impact factor: 1.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.